Atlas Trials

The TRansendocardial Stem Cell Injection Delivery Effects on Neomyogenesis STudy (The TRIDENT Study)

Clinical trial NCT02013674 · COMPLETED

Trial details

NCT number
NCT02013674
Sponsor
Joshua M Hare
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Ischemic Left Ventricular DysfunctionMyocardial Infarction
Start date
2014-02-13
Primary completion
2017-03-02
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.